1: Albash R, Ragaie MH, Hassab MAE, El-Haggar R, Eldehna WM, Al-Rashood ST, Mosallam S. Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv. 2022 Dec;29(1):1100-1111. doi: 10.1080/10717544.2022.2057619. PMID: 35373684; PMCID: PMC8986243.
2: Ahmed S, Amin MM, Sayed S. A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration. Drug Deliv. 2023 Dec;30(1):2179129. doi: 10.1080/10717544.2023.2179129. PMID: 36788709; PMCID: PMC9930819.
3: Ahmed S, Amin MM, El-Korany SM, Sayed S. Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: Preparation, in vitro characterization, ex vivo and in vivo assessments. Drug Deliv. 2022 Dec;29(1):2428-2441. doi: 10.1080/10717544.2022.2103600. PMID: 35880688; PMCID: PMC9341384.
4: Fernández-Alba J, Valle-Gay A, Dibildox M, Vargas JA, González J, García M, López LH; Fentimex Mexican Study Group. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. J Chemother. 2004 Apr;16(2):179-86. doi: 10.1179/joc.2004.16.2.179. PMID: 15216954.
5: Albash R, Al-Mahallawi AM, Hassan M, Alaa-Eldin AA. Development and Optimization of Terpene-Enriched Vesicles (Terpesomes) for Effective Ocular Delivery of Fenticonazole Nitrate: In vitro Characterization and in vivo Assessment. Int J Nanomedicine. 2021 Jan 26;16:609-621. doi: 10.2147/IJN.S274290. Erratum in: Int J Nanomedicine. 2022 Aug 08;17:3509-3510. PMID: 33531804; PMCID: PMC7847387.
6: Feng Z, Zou Q, Tan X, Che W, Zhang Z. Determination of fenticonazole enantiomers by LC-ESI-MS/MS and its application to pharmacokinetic studies in female rats. Arzneimittelforschung. 2011;61(10):587-93. doi: 10.1055/s-0031-1300557. PMID: 22164967.
7: Cohen J. Revue des dernières acquisitions sur les vulvo-vaginites mycosiques: place du nitrate de fenticonazole (Lomexin) dans leur traitement [Review of the latest treatments of vulvovaginal mycoses: role of fenticonazole nitrate (Lomexin) in their treatment]. Contracept Fertil Sex. 1997 May;25(5):396-403. French. PMID: 9273113.
8: Ma L, Lian Y, Tang J, Chen F, Gao H, Zhou Z, Hou N, Yi W. Identification of the anti-fungal drug fenticonazole nitrate as a novel PPARγ-modulating ligand with good therapeutic index: Structure-based screening and biological validation. Pharmacol Res. 2021 Nov;173:105860. doi: 10.1016/j.phrs.2021.105860. Epub 2021 Aug 28. PMID: 34461220.
9: Albash R, Yousry C, Al-Mahallawi AM, Alaa-Eldin AA. Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in- vitro characterization, statistical optimization, and in-vivo assessment. Drug Deliv. 2021 Dec;28(1):1-9. doi: 10.1080/10717544.2020.1859000. PMID: 33322971; PMCID: PMC7744155.
10: Erratum: Development and Optimization of Terpene-Enriched Vesicles (Terpesomes) for Effective Ocular Delivery of Fenticonazole Nitrate: In vitro Characterization and in vivo Assessment [Corrigendum]. Int J Nanomedicine. 2022 Aug 8;17:3509-3510. doi: 10.2147/IJN.S383607. Erratum for: Int J Nanomedicine. 2021 Jan 26;16:609-621. PMID: 35966147; PMCID: PMC9374199.
11: Novelli A, Periti E, Massi GB, Masi R, Mazzei T, Periti P. Systemic absorption of 3H-fenticonazole after vaginal administration of 1 gram in patients. J Chemother. 1991 Feb;3(1):23-7. doi: 10.1080/1120009x.1991.11739058. PMID: 2019858.
12: Albash R, Elmahboub Y, Baraka K, Abdellatif MM, Alaa-Eldin AA. Ultra- deformable liposomes containing terpenes (terpesomes) loaded fenticonazole nitrate for treatment of vaginal candidiasis: Box-Behnken design optimization, comparative ex vivo and in vivo studies. Drug Deliv. 2020 Dec;27(1):1514-1523. doi: 10.1080/10717544.2020.1837295. PMID: 33108907; PMCID: PMC7594706.
13: Graziani G, Cazzulani P. Irritation and toxicity studies with fenticonazole applied topically to the skin and mucous membranes. Arzneimittelforschung. 1981;31(12):2152-4. PMID: 7199317.
14: Muñoz Reyes JR, Villanueva Reynoso C, Ramos CJ, Menéndez Vázquez J, Bailón Uriza R, Vargas AJ. Eficacia y tolerancia de 200 mg de fenticonazol vs 400 mg de miconazol en el tratamiento intravaginal de la vulvovaginitis micótica [Efficacy and tolerance of 200 mg of fenticonazole versus 400 mg of miconazole in the intravaginal treatment of mycotic vulvovaginitis]. Ginecol Obstet Mex. 2002 Feb;70:59-65. Spanish. PMID: 12017948.
15: Ahmed S, Amin MM, El-Korany SM, Sayed S. Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management. Drug Deliv. 2022 Dec;29(1):2945-2958. doi: 10.1080/10717544.2022.2120926. PMID: 36073061; PMCID: PMC9848414.
16: Veronese M, Barzaghi D, Bertoncini A. Antifungal activity of fenticonazole in experimental dermatomycosis and candidiasis. Arzneimittelforschung. 1981;31(12):2137-9. PMID: 7199314.
17: Graziani G, Cazzulani P, Barbadoro E. Toxicological and pharmacological properties of fenticonazole, a new topical antimycotic. Arzneimittelforschung. 1981;31(12):2145-51. PMID: 7199316.
18: Veronese M, Barzaghi D, Bertoncini A, Zadro M. The Salmonella mutagenicity assay on fenticonazole, a new antifungal imidazole derivative. Arzneimittelforschung. 1981;31(12):2140-2. PMID: 7037010.
19: Veronese M, Salvaterra M, Barzaghi D. Fenticonazole, a new imidazole derivative with antibacterial and antifungal activity. In vitro study. Arzneimittelforschung. 1981;31(12):2133-7. PMID: 7199313.
20: Chen F, Ma L, Cai G, Tang J, Wang Y, Liu Q, Liu X, Hou N, Zhou Z, Yi W. Identification of a novel PPARγ modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation. Biomed Pharmacother. 2022 Oct;154:113653. doi: 10.1016/j.biopha.2022.113653. Epub 2022 Sep 7. PMID: 36942599.